Cargando…
Defining a Characteristic Gene Expression Set Responsible for Cancer Stem Cell-Like Features in a Sub-Population of Ewing Sarcoma Cells CADO-ES1
One of the still open questions in Ewing sarcoma, a rare bone tumor with weak therapeutic options, is to identify the tumor-driving cell (sub) population and to understand the specifics in the biological network of these cells. This basic scientific insight might foster the development of more speci...
Autores principales: | Hotfilder, Marc, Mallela, Nikhil, Seggewiß, Jochen, Dirksen, Uta, Korsching, Eberhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321634/ https://www.ncbi.nlm.nih.gov/pubmed/30563222 http://dx.doi.org/10.3390/ijms19123908 |
Ejemplares similares
-
Target discovery screens using pooled shRNA libraries and next-generation sequencing: A model workflow and analytical algorithm
por: Schaefer, Christiane, et al.
Publicado: (2018) -
Splice variants denote differences between a cancer stem cell side population of EWSR1-ERG-based Ewing sarcoma cells, its main population and EWSR1-FLI-based cells
por: Korsching, Eberhard, et al.
Publicado: (2022) -
The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling
por: Berning, Philipp, et al.
Publicado: (2018) -
The Receptor Tyrosine Kinase RON and Its Isoforms as Therapeutic Targets in Ewing Sarcoma
por: Berning, Philipp, et al.
Publicado: (2020) -
Localized Ewing sarcoma of the tibia
por: Kashima, Takeshi G, et al.
Publicado: (2013)